Vancomycin Toxicity Guidelines
Nephrotoxicity
- Acute kidney injury (AKI) is the most common serious adverse effect of high vancomycin levels, characterized by increases in serum creatinine of ≥0.5 mg/dL or 150% increase from baseline, according to Praxis Medical Insights 1
- Risk of nephrotoxicity significantly increases with sustained trough concentrations >20 μg/mL, as reported by Clinical Infectious Diseases 2
Monitoring and Management
- Regular monitoring of trough serum vancomycin concentrations is essential for patients receiving prolonged courses of therapy, as recommended by Clinical Infectious Diseases and Praxis Medical Insights 1 2
- Monitor renal function with serum creatinine measurements, as suggested by Clinical Infectious Diseases and Praxis Medical Insights 1 2
- For patients with symptoms of ototoxicity, consider audiometric evaluation, according to Clinical Infectious Diseases 3
- Hold the next scheduled dose of vancomycin and recheck the trough level before administering subsequent doses, as advised by Praxis Medical Insights 1
- Once the trough level decreases to the target range (15-20 mg/L for serious infections), resume vancomycin at a reduced dose or with an extended dosing interval, as recommended by Praxis Medical Insights 1
- In cases of severe toxicity, especially with significant renal impairment, consider alternative antibiotics, as suggested by Praxis Medical Insights and Clinical Infectious Diseases 1 2
Vancomycin-Induced Nephrotoxicity and BUN Elevation
Monitoring and Management
- The Infectious Diseases Society of America recommends monitoring both serum creatinine and BUN levels regularly during vancomycin therapy, with checks before starting therapy and at regular intervals 4
- Monitoring vancomycin trough levels is crucial, with mandatory trough monitoring required for prolonged therapy (>7 days), although the exact interval is not specified in the provided references 4